Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03463265
Title ABI-009 (Nab-Rapamycin) in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aadi, LLC
Indications

glioblastoma

high grade glioma

Therapies

Lomustine + Nab-rapamycin

Nab-rapamycin

Nab-rapamycin + Temozolomide

Bevacizumab + Nab-rapamycin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.